Cargando…
Aβ43 levels determine the onset of pathological amyloid deposition
About 2% of Alzheimer’s disease (AD) cases have early onset (FAD) and are caused by mutations in either Presenilins (PSEN1/2) or amyloid-β precursor protein (APP). PSEN1/2 catalyze production of Aβ peptides of different length from APP. Aβ peptides are the major components of amyloid plaques, a path...
Autores principales: | Tambini, Marc D., Yin, Tao, Yesiltepe, Metin, Breuillaud, Lionel, Zehntner, Simone P., d'Abramo, Cristina, Giliberto, Luca, D'Adamio, Luciano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404620/ https://www.ncbi.nlm.nih.gov/pubmed/37257821 http://dx.doi.org/10.1016/j.jbc.2023.104868 |
Ejemplares similares
-
Late-long-term potentiation magnitude, but not Aβ levels and amyloid pathology, is associated with behavioral performance in a rat knock-in model of Alzheimer disease
por: Yesiltepe, Metin, et al.
Publicado: (2022) -
Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use
por: d’Abramo, Cristina, et al.
Publicado: (2020) -
Transgenic Expression of the Amyloid-β Precursor Protein-Intracellular Domain Does Not Induce Alzheimer's Disease–Like Traits In Vivo
por: Giliberto, Luca, et al.
Publicado: (2010) -
TNF-α–mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer’s disease pathology in young Trem2(R47H) rats
por: Ren, Siqiang, et al.
Publicado: (2020) -
Beyond amyloid: altered gene function in neurodegenerative diseases
por: Yesiltepe, Metin, et al.
Publicado: (2023)